| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.12 | 0.5 |